Evolve Biologics Inc. offers the development and commercialization of plasma-derived therapeutics, using its proprietary PlasmaCap EBA purification technology to more efficiently and effectively meet growing global patient demand for these life-saving products. The Company is currently in the process of commercializing an exciting and innovativeportfolio of product candidates, including IVIG (intravenous immunoglobulin) and Albumin (human serum albumin), both of which are in advanced stages of regulatory approval in the US (FDA) and Canada (Health Canada).

Biotechnology

Health Care

Evolve Biologics

James Caggiano

Trevor Seelert, P. Eng

Madhuja Gupta

Mark Krause

Kelly McNeely

Gillian Vanderlee

Domenic Rizzuto

David Holliday

Dave Miller

Chris Carr

Carolyn Koerner

The Laboratory and Research team at Evolve Biologics focuses on the development and optimization of plasma-derived therapeutics. This team is responsible for conducting analytical research, developing and transferring assays, managing lab operations, and engineering purification processes, utilizing the proprietary PlasmaCap EBA technology to ensure the efficacy and safety of products like IVIG and human serum albumin.

Laboratory and Research

Facility and Operations Team

Leadership Team

Laboratory and Research

About

Team members

Other teams at Evolve Biologics

Facility and Operations Team

Leadership Team